EUVIMEDEUVIMED entdecken
Crossref

Clinical efficacy of Nd:YAG-laser combined with hyaluronic acid and trehalose injections in patients with erythematotelangiectatic rosacea

G. А. Naumchik, M. M. Trukhachev, V. P. Zhuk, V. S. Murakova

Meditsinskiy sovet = Medical Council · 16.04.2026 · (2) · 147-159

DOI: 10.21518/ms2026-057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 16.04.2026. Verfasst von G. А. Naumchik und 3 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Erythematotelangiectatic rosacea, the most prevalent subtype, is characterized by its resistance to standard therapeutic approaches. A combination of laser treatment for vascular lesions and injectable biorevitalization for the functional dermal remodeling appears pathogenetically justified. However, its clinical efficacy and safety require further investigation.

Aim

To assess the clinical efficacy and safety of Nd:YAG-laser combined with hyaluronic acid/trehalose injections within a single procedure or with 2-week interval in patients with erythematotelangiectatic rosacea. Materials and methods . In this study, 20 patients diagnosed with erythematotelangiectatic rosacea were allocated to four groups: Group 1 (laser treatment combined with hyaluronic acid/trehalose injections within a single procedure); Group 2 (laser treatment combined with hyaluronic acid/trehalose injections with 2-week interval); Group 3 (laser treatment); Group 4 (hyaluronic acid/trehalose injections). Treatment outcomes were monitored using Antera 3D® three-dimensional skin analysis and validated clinical assessment and patient satisfaction scales.

Results

Combination therapy (Groups 1 and 2) demonstrated the most significant reduction of erythema, telangiectasia and vascular lesions. These approaches were associated with the greatest improvements in overall skin condition and patient satisfaction. No significant difference between Groups 1 and 2 was found. Nd:YAG-laser monotherapy proved most effective for the reduction of vascular lesions, it had no significant impact on skin quality parameters. Hyaluronic acid/trehalose injections improved skin hydration and texture, however demonstrated limited efficacy against telangiectasias.

Conclusion

The high efficacy and safety of Nd:YAG-laser combined with hyaluronic acid/trehalose injections both within a single procedure and with 2-week intervals support the inclusion of these treatment protocols in clinical algorithms for erythematotelangiectatic rosacea.

Zitieren

APA

Naumchik, G. А., Trukhachev, M. M., Zhuk, V. P., & Murakova, V. S. (2026). Clinical efficacy of Nd:YAG-laser combined with hyaluronic acid and trehalose injections in patients with erythematotelangiectatic rosacea. Meditsinskiy sovet = Medical Council, 147-159. https://doi.org/10.21518/ms2026-057

Vancouver

Naumchik GА, Trukhachev MM, Zhuk VP, Murakova VS. Clinical efficacy of Nd:YAG-laser combined with hyaluronic acid and trehalose injections in patients with erythematotelangiectatic rosacea. Meditsinskiy sovet = Medical Council. 2026:147-159. doi:10.21518/ms2026-057

BibTeX
@article{Naumchik2026,
  author = {Naumchik, G. А. and Trukhachev, M. M. and Zhuk, V. P. and Murakova, V. S.},
  title = {Clinical efficacy of Nd:YAG-laser combined with hyaluronic acid and trehalose injections in patients with erythematotelangiectatic rosacea},
  journal = {Meditsinskiy sovet = Medical Council},
  year = {2026},
  number = {2},
  pages = {147--159},
  doi = {10.21518/ms2026-057}
}
Kostenlos starten →